Unknown

Dataset Information

0

A randomized, placebo- and active-controlled, multi-country, multi-center parallel group trial to evaluate the efficacy and safety of a fixed-dose combination of 400 mg ibuprofen and 100 mg caffeine compared with ibuprofen 400 mg and placebo in patients with acute lower back or neck pain.


ABSTRACT: Background:Ibuprofen is a well-established analgesic for acute pain symptoms. In several acute pain models, caffeine has demonstrated an analgesic adjuvant effect. This randomized trial (NCT03003000) was designed to compare the efficacy of a fixed-dose combination of ibuprofen and caffeine with ibuprofen or placebo for the treatment of acute lower back/neck pain. Methods:Patients with acute lower back/neck pain resulting in pain on movement (POM) ?5 on a 10-point numerical rating scale were randomized 2:2:1 to receive orally, three times daily for 6 days, 400 mg ibuprofen+100 mg caffeine, 400 mg ibuprofen or placebo, respectively. The primary endpoint was change in POMWP (POM triggering highest pain score at baseline [worst procedure]) between baseline and the morning of day 2. Key secondary endpoints included POMWP area under curve (AUC) between baseline and the morning of day 4 (POMWPAUC72h) and day 6 (POMWPAUC120h). Results:In total, 635 patients were randomized (256 ibuprofen + caffeine: 253 ibuprofen: 126 placebo). Active treatments exhibited similar reductions in POMWP, with an adjusted mean reduction of 1.998 (standard error [SE]: 0.1042) between baseline and day 2 for ibuprofen, 1.869 (SE: 0.1030) for ibuprofen + caffeine and 1.712 (SE: 0.1422) for placebo. Similar results were observed for POMWPAUC72h and POMWPAUC120h. Safety and tolerability was as expected. Conclusion:A decrease in lower back/neck pain, indicated by reduced POMWP, was shown in all active treatment arms; however, treatment effects were small versus placebo. Ibuprofen plus caffeine was not superior to ibuprofen alone or placebo for the treatment of acute lower back/neck pain in this setting.

SUBMITTER: Predel HG 

PROVIDER: S-EPMC6765100 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

A randomized, placebo- and active-controlled, multi-country, multi-center parallel group trial to evaluate the efficacy and safety of a fixed-dose combination of 400 mg ibuprofen and 100 mg caffeine compared with ibuprofen 400 mg and placebo in patients with acute lower back or neck pain.

Predel Hans-Georg HG   Ebel-Bitoun Caty C   Lange Robert R   Weiser Thomas T  

Journal of pain research 20190923


<h4>Background</h4>Ibuprofen is a well-established analgesic for acute pain symptoms. In several acute pain models, caffeine has demonstrated an analgesic adjuvant effect. This randomized trial (NCT03003000) was designed to compare the efficacy of a fixed-dose combination of ibuprofen and caffeine with ibuprofen or placebo for the treatment of acute lower back/neck pain.<h4>Methods</h4>Patients with acute lower back/neck pain resulting in pain on movement (POM) ≥5 on a 10-point numerical rating  ...[more]

Similar Datasets

| S-EPMC6767367 | biostudies-literature
| S-EPMC5297880 | biostudies-literature
| S-EPMC8585829 | biostudies-literature
| S-EPMC3496952 | biostudies-literature
| S-EPMC3594886 | biostudies-literature
| S-EPMC4701182 | biostudies-literature
| S-EPMC8146561 | biostudies-literature
| S-EPMC7445310 | biostudies-literature
| S-EPMC7020555 | biostudies-literature
| S-EPMC8941850 | biostudies-literature